Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Asthma / August 2004

Tip: Looking for answers? Try searching our database.

Asthma research on the wrong trail

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
Richard Friedel - 28 Aug 2004 09:17 GMT
Joy wrote on "Breath holding and asthma"

"Whatever. I view it as immaterial. No one wants to spend their lives
taking
meds, or in breathing exercises. They just want what everyone else has
- the
ability to breath without thinking about it. Again, the best HOPE of
figuring this all out rests with the people who are looking at the
CAUSES of
asthma. Clearly there is  more than one."

But can you honestly say, judging from your experience with human
nature,  that research might not be  barking up the wrong tree?  Could
not the mystery behind asthma be due to a misunderstanding? Dr. Rolf
Hubmayr  (Am J Respir Crit Care Med Vol 165. pp 1647–1653, 2002)
complains of  the critical care community's tunnel vision (on
ventilating patients).

Specifically, ongoing asthma research is largely concentrated on
molecular and cellular biology. This might be due to a logical fallacy
as follows:

1 Symptomatic treatment with drugs is presently paramount  in asthma
treatment.

2 Therefore such drugs provide a strong lead to a cause of asthma
being at the molecular or cellular level.

However, since symptomatic and causal treatment may bear no relation
to each other, this hypothesis seems too weak in comparison with
theories  that there is some self-limiting factor like carbon dioxide
accumulating (Buteyko, has been disproved) or inspiratory muscles
adapting to cope with increased load in asthma (implied by Weiner,
Chest 1992, 1357-61,
http://www.findarticles.com/p/articles/mi_m0984/is_n5_v102/ai_12940162/pg_1).
Then, it could follow that asthma drugs might tend to torpedo such
adaptation, while being paradoxically acclaimed as beneficial.

As witnessed by the activities of ethics commissions giving permission
to test asthma and other drugs, there is the principle that probands
(those taking part in such tests) should not be denied an effective
treatment.  It would not be permissible to stop  probands from taking
any (normally needed) effective medication in the sham treatment
(placebo or control) group, while the other group took the new
medication to be tested.

This principle should apparently override the principle of free
enterprise that drug companies are allowed to fully focus their
activities on drug development.  They should, as a moral duty, have
control groups in asthma research using breathing methods and if such
methods are not adequately tested so far then such testing (which is
unfortunately comparatively expensive)should be funded. Regards,
Richard Friedel
Joy - 28 Aug 2004 14:54 GMT
> Joy wrote on "Breath holding and asthma"
>
[quoted text clipped - 17 lines]
> molecular and cellular biology. This might be due to a logical fallacy
> as follows:

I don't see that treatment for asthma with drugs has anything to due with
the reason they are looking at cell biology. I was told that doctors have to
hit everyone with a shotgun approach right now because they don't know
specifically what will work for an individual person. You know, how some
drugs work without side effects for one person while the next is left not
only without relief, but with unbareable side effects. Understanding the
genetics will allow them to more accurately prescribe the drug which has
been shown to help people with that genetic makeup. We are all just so
different, it isn't like A single drug is likely to work well for everyone.

> 1 Symptomatic treatment with drugs is presently paramount  in asthma
> treatment.
[quoted text clipped - 8 lines]
> adapting to cope with increased load in asthma (implied by Weiner,
> Chest 1992, 1357-61,

http://www.findarticles.com/p/articles/mi_m0984/is_n5_v102/ai_12940162/pg_1).
> Then, it could follow that asthma drugs might tend to torpedo such
> adaptation, while being paradoxically acclaimed as beneficial.
[quoted text clipped - 6 lines]
> (placebo or control) group, while the other group took the new
> medication to be tested.

I am not certain what you are implying. I have never heard of a company who
in testing would tell you to deny yourself your asthma meds. They may deny
you their really great, or not so great, not yet marketed product. I have a
chemistry friend in California whose company was testing a new drug for
Lupus which was so successful that the company gave everyone a chance to try
the drug before the trial ended. So some companies do take care of the
participants. I have also heard of studies which don't complete (time wise)
because the results were so significant, the researchers no longer needed to
test. How, other than testing, do you propose they get this information
about efficacy? Side effects?

> This principle should apparently override the principle of free
> enterprise that drug companies are allowed to fully focus their
[quoted text clipped - 3 lines]
> unfortunately comparatively expensive)should be funded. Regards,
> Richard Friedel

Why breathing methods? The is no innate reason to pick breathing methods.
Why not try the Doe approach or the cow dung. Which breathing method? You
could go nuts as a researcher trying to appease all you guys.

Joy
Richard Friedel - 29 Aug 2004 09:51 GMT
> I am not certain what you are implying. I have never heard of a company who
> in testing would tell you to deny yourself your asthma meds. They may deny
> you their really great, or not so great, not yet marketed product. .....

Yes, probands (persons  in a clinical test) in the control or sham
treatment group, could not be prevented from taking satisfactory state
of the art meds. Such denial would be prevented by the relevant ethics
commission.

However you could, I think; easily extend  this moral duty to
considering other treatments.  If, as you seem to consider a repulsive
thought (:- o  any non-drug treatment has a good status, then probands
normally using it could be considered as a control group as well,
whereas the other group would be treated with the new drug.  The logic
may not be accepted by all, but there is the danger of drug companies
specializing too much on comparing drugs with each other and so simply
small timing. As we all know, medicine as the art of healing cannot be
commercialized, or at any rate, not to an unlimited extent.

On the distinction between breathing techniques and obviously lunatic
fringe stuff (doe and cow dung), see Weiner as a leading authority on
asthma (Chest 1992 1357-61).

"In addition, circumstantial evidence exists to suggest that the
inspiratory muscles may suffer damage during an acute asthmatic attack
that may lead to acute respiratory failure."

He states that his muscle training  and his interpretation of asthma
as being largely a muscular condition to be treated by breathing, is a
valuable method and perspective.  His method or at any rate other
breathing methods (counting to slow respiration rate, pursed lips
breathing) curb attacks.

Therefore, it could be plausibly argued, the optimum state of the art
treatment given to asthmatic probands in a control group getting
should not be limited to drugs. Likewise, it would be no good finding
some asthmatics normally undergoing substandard treatment and using
them as probands, even if some ethics commission allowed it.

I do know that many (as a sort of silent majority) think that
breathing techniques have next to no effect on asthma and that this
would seem to be almost axiomatic and sort of common sense, but the
competently researched SIMT stuff seems to provide a proof that this
is not so. Regards,  Richard Friedel
Joy - 29 Aug 2004 11:14 GMT
> > I am not certain what you are implying. I have never heard of a company who
> > in testing would tell you to deny yourself your asthma meds. They may deny
[quoted text clipped - 4 lines]
> of the art meds. Such denial would be prevented by the relevant ethics
> commission.

> However you could, I think; easily extend  this moral duty to
> considering other treatments.  If, as you seem to consider a repulsive
[quoted text clipped - 5 lines]
> small timing. As we all know, medicine as the art of healing cannot be
> commercialized, or at any rate, not to an unlimited extent.

I don't feel that there is a moral duty of a drug company to test your ideas
out for free. They make profits from the production of drugs - that is the
reason for their existance. Furthermore, they may so confuse the picture by
letting the control group do something that is not a control, their results
would be invalidated. Wasted test. No new product. It will never happen.

> On the distinction between breathing techniques and obviously lunatic
> fringe stuff (doe and cow dung), see Weiner as a leading authority on
[quoted text clipped - 3 lines]
> inspiratory muscles may suffer damage during an acute asthmatic attack
> that may lead to acute respiratory failure."

That is an exception and those people whose asthma is so severe they
experience disabling attacks would never make it into the test. No
researcher likes having someone die on them. Now I know that people with
COPD are particularly incouraged to use breathing devices, particularly
after a heart attack.

> He states that his muscle training  and his interpretation of asthma
> as being largely a muscular condition to be treated by breathing, is a
[quoted text clipped - 13 lines]
> competently researched SIMT stuff seems to provide a proof that this
> is not so. Regards,  Richard Friedel

I disagree. I think that the majority think that SIMT stuff has no effect.
The army tried that in WWI and you may not have noticed, but almost no one
uses it anymore. They must find the asthma meds more satisfactory. People
use what works.

I did see a report out of Britain that said the number of asthmatics who had
tried alternative treatments was pretty small - 6%. That would vary culture
to culture I suspect. But that coincides with the report Dr Enright quoted
that 80% of asthmatics are satisfactorily controlled by asthma meds. Those
who are doing fine are not out there looking for answers. So I expect
nothing much will come of any altmed treatment.

Joy
NorthShoreCEO - 28 Aug 2004 16:24 GMT
>> Specifically, ongoing asthma research is largely concentrated
on
> molecular and cellular biology.

Post links to your sources that state this, please.

> As witnessed by the activities of ethics commissions giving permission
> to test asthma and other drugs, there is the principle that probands
[quoted text clipped - 11 lines]
> unfortunately comparatively expensive)should be funded. Regards,
> Richard Friedel

According to you, Richard, breathing exercises will solve all
their asthma problems, and since all participants would have to
do the breathing exercises, this would really skew the study.
(said, tongue in cheek)

You have no understanding of what clicinal trials are about.  I'd
stop now if I were you.
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2009 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.